Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Complement factor H-antibody-associated hemolytic uremic syndrome: pathogenesis, clinical presentation, and treatment.

Seminars in thrombosis and hemostasis - 1 Jun 2014

Hofer Johannes, Giner Thomas, Józsi Mihály

Abstract excerpt

The presence of circulating autoantibodies, primarily to complement factor H antibodies (CFH-Abs) in plasma characterizes the autoimmune form of atypical hemolytic uremic syndrome (aHUS). This acquired form of aHUS defines a distinct subgroup of aHUS patients, which requires diagnostic and treatment approaches in part different from those of the genetically defined forms. The mechanisms leading to CFH-Ab...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Humanized
Share to Atypical Hemolytic Uremic Syndrome

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Autoantibodies

Share to Clinical Trials as Topic

Share to Complement C3b Inactivator Proteins

Share to Complement Factor H

Share to Kidney Transplantation

Share to Protein Structure, Tertiary

Source

Identifiers

PMID: 24799303
DOI: 10.1055/s-0034-1375297

Genes

CFH

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Complement factor H-antibody-associated hemolytic uremic syndrome: pathogenesis, clinical presentation, and treatment.PMID 24799303Read ↗

Atypical hemolytic uremic syndrome: update on the complement system and what is new.Semantic proximity Read ↗

Anti-factor B antibodies in atypical hemolytic uremic syndromeSemantic proximity Read ↗

Anti-complement factor H (CFH) antibodies and a novel CFH gene mutation in an atypical hemolytic uremic syndrome patient with complement activation of the classical pathway.Semantic proximity Read ↗

Atypical hemolytic uremic syndrome.Semantic proximity Read ↗

Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations.Semantic proximity Read ↗

Haemolytic uraemic syndrome.Semantic proximity Read ↗

Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency.Semantic proximity Read ↗

New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab.Semantic proximity Read ↗

Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics.Semantic proximity Read ↗

Atypical hemolytic uremic syndrome: Korean pediatric series.Semantic proximity Read ↗

Atypical Hemolytic Uremic Syndrome Associated with Complement Factor H Mutation and IgA Nephropathy: A Case Report Successfully Treated with Eculizumab.Semantic proximity Read ↗

Complement-mediated HUS revisited: evolving insights into pathophysiology, diagnosis, and treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.